Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review

December 2021 | 100 pages | ID: B637F6D38AAEN
GlobalData

Abstracts

Bristol-Myers Squibb Co (BMY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – Analyst’s summarization of the company’s business strategy.
• SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
• Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
• Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Bristol-Myers Squibb Co (BMS) is a specialty biopharmaceutical company that discovers, develops, licenses and manufactures medicines, and markets, distributes and sells them to patients with serious diseases. Its primary focus is on cancer, cardiovascular, immunology and fibrotic therapeutic projects. The company offers its products across the world to wholesalers, retail pharmacies, hospitals, medical professionals and government entities. BMS provides its products in the US, Europe, Japan and other countries. The company conducts research to focus on the discovery and development of novel medicines that address serious diseases in areas of significant unmet medical need. BMS is headquartered in New York City, New York, the US.

Bristol-Myers Squibb Co Key Recent Developments

Dec 01,2021: We The Patriots USA: Major federal lawsuit filed by employees against Bristol Myers Squibb
Nov 04,2021: Bristol Myers Squibb to highlight more than 80 abstracts at ASH 2021 demonstrating strength of innovative therapeutic platforms improving outcomes for a broad range of hematologic diseases
Nov 03,2021: Bristol Myers Squibb data at ACR Convergence 2021 Illustrate Scientific Advances for immune-mediated rheumatic diseases
Oct 28,2021: Bristol Myers reports $11.62bn total revenue in Q3 2021
Oct 27,2021: Bristol Myers Squibb Reports Third Quarter Financial Results for 2021

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

• The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

• The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

• Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.

• Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

• Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Contents

SECTION 1 - ABOUT THE COMPANY

Bristol-Myers Squibb Co - Key Facts
Bristol-Myers Squibb Co - Key Employees
Bristol-Myers Squibb Co - Key Employee Biographies
Bristol-Myers Squibb Co - Major Products and Services
Bristol-Myers Squibb Co - History
Bristol-Myers Squibb Co - Company Statement
Bristol-Myers Squibb Co - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Joint Venture

SECTION 2 – COMPANY ANALYSIS

Company Overview
Bristol-Myers Squibb Co - Business Description
Business Segment: BioPharmaceuticals
Overview
Performance
Geographical Segment: Europe
Performance
Geographical Segment: Others
Performance
Geographical Segment: Rest of the World
Performance
Geographical Segment: The US
Performance
R&D Overview
Bristol-Myers Squibb Co - Corporate Strategy
Bristol-Myers Squibb Co - SWOT Analysis
SWOT Analysis - Overview
Bristol-Myers Squibb Co - Strengths
Bristol-Myers Squibb Co - Weaknesses
Bristol-Myers Squibb Co - Opportunities
Bristol-Myers Squibb Co - Threats
Bristol-Myers Squibb Co - Key Competitors

SECTION 3 – COMPANY FINANCIAL RATIOS

Financial Ratios - Capital Market Ratios
Financial Ratios - Annual Ratios
Performance Chart
Financial Performance
Financial Ratios - Interim Ratios
Financial Ratios - Ratio Charts

SECTION 4 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bristol-Myers Squibb Co, Recent Deals Summary

SECTION 5 – COMPANY’S RECENT DEVELOPMENTS

Dec 01, 2021: We The Patriots USA: Major federal lawsuit filed by employees against Bristol Myers Squibb
Nov 04, 2021: Bristol Myers Squibb to highlight more than 80 abstracts at ASH 2021 demonstrating strength of innovative therapeutic platforms improving outcomes for a broad range of hematologic diseases
Nov 03, 2021: Bristol Myers Squibb data at ACR Convergence 2021 Illustrate Scientific Advances for immune-mediated rheumatic diseases
Oct 28, 2021: Bristol Myers reports $11.62bn total revenue in Q3 2021
Oct 27, 2021: Bristol Myers Squibb Reports Third Quarter Financial Results for 2021
Sep 20, 2021: New cancer therapies continue to develop and give hope in rapidly improving oncology space
Sep 10, 2021: Bristol Myers Squibb shares research supporting correlation between New York Heart Association Functional Class (NYHA class) and Mortality in Obstructive Hypertrophic Cardiomyopathy
Sep 08, 2021: Bristol Myers Squibb research at ESMO 2021 demonstrates clinical benefits of immunotherapies in multiple hard-to-treat advanced or metastatic cancers and reinforces the benefit of Opdivo in earlier-stage cancers
Sep 07, 2021: Bristol Myers Squibb to Take Part in Morgan Stanley 19th Annual Global Healthcare Conference
Sep 07, 2021: Updated Statement: Bristol Myers Squibb on Coronavirus (COVID-19)

SECTION 6 – APPENDIX

Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Bristol-Myers Squibb Co, Key Facts
Bristol-Myers Squibb Co, Key Employees
Bristol-Myers Squibb Co, Key Employee Biographies
Bristol-Myers Squibb Co, Major Products and Services
Bristol-Myers Squibb Co, History
Bristol-Myers Squibb Co, Subsidiaries
Bristol-Myers Squibb Co, Joint Venture
Bristol-Myers Squibb Co, Key Competitors
Bristol-Myers Squibb Co, Ratios based on current share price
Bristol-Myers Squibb Co, Annual Ratios
Bristol-Myers Squibb Co, Annual Ratios (Cont...1)
Bristol-Myers Squibb Co, Annual Ratios (Cont...2)
Bristol-Myers Squibb Co, Interim Ratios
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021
Bristol-Myers Squibb Co, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List Of Figures

LIST OF FIGURES

Bristol-Myers Squibb Co, Performance Chart (2016 - 2020)
Bristol-Myers Squibb Co, Ratio Charts
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021
Bristol-Myers Squibb Co, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021